Covestor’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
2,346
+916
| +64% | +$50.4K | 0.08% | 405 |
|
|
2025
Q1 | $101K | Buy |
1,430
+152
| +12% | +$10.7K | 0.07% | 480 |
|
|
2024
Q4 | $84K | Buy |
1,278
+248
| +24% | +$16.3K | 0.05% | 618 |
|
|
2024
Q3 | $72K | Buy |
1,030
+794
| +336% | +$55.5K | 0.05% | 706 |
|
|
2024
Q2 | $19K | Sell |
236
-393
| -62% | -$31.6K | 0.01% | 1212 |
|
|
2024
Q1 | $55K | Sell |
629
-34
| -5% | -$2.97K | 0.03% | 844 |
|
|
2023
Q4 | $64K | Sell |
663
-104
| -14% | -$10K | 0.04% | 739 |
|
|
2023
Q3 | $68K | Buy |
767
+95
| +14% | +$8.42K | 0.05% | 623 |
|
|
2023
Q2 | $58K | Sell |
672
-1
| -0.1% | -$86 | 0.04% | 716 |
|
|
2023
Q1 | $66K | Buy |
673
+336
| +100% | +$33K | 0.06% | 591 |
|
|
2022
Q4 | $35K | Buy |
337
+169
| +101% | +$17.6K | 0.03% | 864 |
|
|
2022
Q3 | $14K | Sell |
168
-1
| -0.6% | -$83 | 0.01% | 1112 |
|
|
2022
Q2 | $14K | Sell |
169
-4
| -2% | -$331 | 0.01% | 1070 |
|
|
2022
Q1 | $13K | Buy |
173
+73
| +73% | +$5.49K | 0.01% | 1203 |
|
|
2021
Q4 | $9K | Buy |
+100
| New | +$9K | 0.01% | 1044 |
|